• Cancel
    Date：2021-11
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=793

    Brain Doctor Group (BDG), China's first physician group to establish a specialized brain hospital, announced today the closing of a RMB 200 million Series C financing. Led by Sequoia China, t

  • Cancel
    Date：2021-11
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=795

    Beijing Changmugu Medical Technology Co., Ltd. (referred to as 'Changmugu'), a leading provider of integrated intelligent surgical solutions for orthopedics, announced the closing of a RMB 540 million Series B financing. The funding was jointly led by CIC

  • Cancel
    Date：2021-10
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=796

    Beijing Bio-Bank Corporation ("Bio-Bank"), a biopharmaceutical company specializing in large molecule drug development, announced the successful closing of a hundred million RMB Series A financing, led by CDH Investments. CEC Capital served as the exclus

  • Cancel
    Date：2021-10
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=797

    Shanghai BiOligo Biotech Co., Ltd. (referred to as "BiOligo"), a leading supplier of in vitro diagnostics and nucleic acid drug raw materials, recently closed a RMB 300 million Series A financing. The funding was led by The Carlyle Group, a global leading

  • Cancel
    Date：2021-09
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=789

    On September 26th, Peak Sports, a leading sports brand in China, announced a strategic investment of nearly RMB 1.5 billion from China Resources Guodiao Xiamen Consumption Fund, with participation from several state-owned fund companies such as CCB Trust

  • Cancel
    Date：2021-09
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=800

    Xinyi Information Technology, a provider of Internet of Things (IoT) intelligent terminal system SoC chips, recently closed nearly RMB 500 million in its Series B financing. The funds will primarily be used to strengthen chip research and development, imp

  • Cancel
    Date：2021-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=801

    OrbusNeich Medical Group Limited ("OrbusNeich"), a global leader in vascular intervention devices, recently announced it successfully raised $200 million, led by Shenzhen Capital Group, with participation from CCB International, Star River Capital, Wanhui

  • Cancel
    Date：2021-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=802

    CBridge Capital, a healthcare-focused investment firm, recently announced its investment in Beijing Anhejialier Technology Co., Ltd. ("Anhejialier"), a leading company in the field of ultrasonic knives. This investment represents CBridge Capital's strong

  • Cancel
    Date：2021-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=803

    Innovative drug development company Lynk Pharma recently announced the successful closing of a $50 million in its Series B financing. The round was led by Lilly Asian Ventures, with participation from New Alliance Capital and HeDa Investment., as well as